1. Scrip
  2. >>Focus On Asia
  3. >>India

India Cuts Prices Of 463 Anticancers But Loose Ends Remain

 
• By Anju Ghangurde

Prices of over 400 anticancers have been revised downwards in India by the capping of trade margins, but some healthcare activists say that real benefits for patients could still be elusive. Pharma is also required to maintain production volumes in the new scenario – will it pinch?

Coins
PRICES OF MORE THAN 400 CANCER DRUGS HAVE BEEN CUT IN INDIA

India has effected sharp price cuts for over 400 anticancers by reining in runaway trade margins, bringing relief for patients and opening up prospects for expanded use of the approach across categories of medicines, though some activists dubbed the move as superficial.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia